Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses. Zhang W, Prevost J, Sloan A, Tamming L, et al. Antiviral Res 2025;243:106284.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang W, Prevost J, Sloan A, Tamming L, et al. Intranasal vaccine induces broad and long-lasting immunity against the hemagglutinin stem of group 2 influenza A viruses. Antiviral Res 2025;243:106284.
PMID: 41015121